L-forms of Staphylococcus epidermidis induced by penicillin

Joanna Wróblewska1, Grazyna Janicka, Eugenia Gospodarek

  • 1Nicolaus Copernicus University, Collegium Medicum in Bydgoszcz, Department of Microbiology ul. M. Skłodowskiej-Curie 9, 85-094 Bydgoszcz, Poland.

Insights

This study explored how often Staphylococcus epidermidis can form L-forms, which lack cell walls, when exposed to penicillin. It investigated if the source of the bacteria or the duration of antibiotic exposure impacts L-form induction frequency.

Area of Science:

  • Microbiology
  • Bacterial Pathogenesis
  • Antibiotic Resistance

Background:

  • Staphylococcus epidermidis is a common cause of nosocomial infections.
  • Bacterial L-forms, lacking cell walls, are associated with persistent infections and treatment challenges.
  • Understanding L-form induction is crucial for developing effective antimicrobial strategies.

Purpose of the Study:

  • To determine the frequency of L-form induction in clinical strains of Staphylococcus epidermidis.
  • To assess the influence of the origin of clinical isolates on L-form induction rates.
  • To investigate the impact of antibiotic exposure duration on L-form formation.

Main Methods:

  • Induction of L-forms using a specialized L-form medium with penicillin at 35°C.
  • Culturing and analysis of clinical strains of Staphylococcus epidermidis.
  • Quantitative assessment of L-form induction frequency.

Main Results:

  • Variable frequencies of L-form induction were observed across different clinical strains.
  • The origin of the clinical strains did not show a consistent effect on L-form induction rates.
  • Antibiotic exposure time influenced the frequency of L-form induction, with longer exposure potentially increasing rates.

Conclusions:

  • Staphylococcus epidermidis exhibits variable susceptibility to L-form induction.
  • L-form induction is a complex phenomenon influenced by bacterial strain and antibiotic treatment parameters.
  • Further research is needed to elucidate the mechanisms and clinical implications of L-form induction in S. epidermidis infections.

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...